Map kinases

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 10.07.2021

Dieser Artikel auf Deutsch

Synonym(s)

MAP; MAPK; MAP Kinase; mitogen-activated protein kinases

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

MAP kinases (MAP stands for"mitogen-activated protein") belong to the class of protein kinases and here again to the serine/threonine kinases.

MAP kinases are important key enzymes of cell metabolism and phosphorylate proteins at serine or threonine residues. MAP kinases are part of highly conserved signaling cascades that control the induction and regulation of various phases of the cell cycle, including cell growth, differentiation, apoptosis, and migration.

Chemically, MAP kinases are protein kinases (molar mass 36-44 kDa) that phosphorylate other proteins at specific serine/threonine residues (serine-threonine kinases).

MAP kinases (MAP-K) are directly activated by phosphorylation at two sites: a tyrosine residue and a threonine residue. Phosphorylation occurs through MAP-KK(MAP kinase kinase; see MAP kinase signaling pathway below).

Activated MAP kinases accumulate in the nucleus and phosphorylate nuclear transcription factors. This regulates a large number of target genes and thus numerous key cellular functions. As soon as the MAP kinases are dephosphorylated and thus inactivated, they redistribute in the cytosol and are available for further activation cycles.

Note(s)This section has been translated automatically.

The high mutation rate in the MAP kinase signalling pathway highlights its key role in melanoma genesis. A growth factor that is often pathologically activated by mutation or amplification in this signaling pathway is the KIT receptor, which is mainly altered in acute (36%) and mucosal (39%) melanomas and in melanomas of chronically light-exposed skin.

Orally available multi-kinase inhibitors (e.g. sorafenib) now play an important role in oncology.

Authors

Last updated on: 10.07.2021